Syngene provides transcript of Q2 FY2027 earnings call

Investor Communications View source PDF Explain this filing

SYNGENE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.8%Reaction day

₹414.50

prior close

₹416.00

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.4%-2.2% vs market

Healthcare Research Analytics & Technology peers, median of 5sector-0.5%-1.2% vs sector

On the reaction day the stock moved 2.2 pts less than Nifty Smallcap 250 and 1.2 pts less than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.3

15m

-0.6

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.8+0.4-2.2-0.5-1.2

Next day

+1.0+2.4-1.4+0.5+0.4

-0.3+3.2-3.5+1.2-1.5

+0.2pendingpending-1.8+2.0

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syngene International told NSE and BSE that the transcript from its October 28, 2026 Q2 FY2027 earnings call is available on its website. The filing only provides a link and contains no results, forecasts, targets, or financial details.

Likely market impact

The filing has no direct financial impact. Investors may need to read the linked transcript for operational or outlook comments.